PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1477127
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1477127
Fluorescent in Situ Hybridization Probe Market size was valued at USD 993.20 Million in 2023, expanding at a CAGR of 7.91% from 2024 to 2032.
FISH, or Fluorescence In Situ Hybridization, is a cytogenetic method utilized for the detection and localization of specific DNA sequences on chromosomes. This technique relies on nucleic acid base pairing, where only regions of the chromosome with a high level of sequence complementarity will be identified and bound by fluorescent probes. The process involves the use of probes containing a fluorescent dye that can be tailored for any gene sequence. These probes are introduced to a cell or tissue sample, searching for their DNA counterparts on the chromosome. Upon binding, fluorescence is triggered, allowing researchers to easily identify them under special lighting.
Fluorescent in Situ Hybridization Probe Market- Market Dynamics
Increasing awareness among people regarding early diagnosis of various genetic and chronic disorders are anticipated to drive the growth of market
The prevalence of genetic and chronic disorders is increasing worldwide, creating a greater demand for accurate and efficient diagnostic methods. FISH probes are highly sensitive and specific, making them an ideal tool for detecting genetic abnormalities associated with various disorders. According to the World Health Organization, genetic disorders and congenital abnormalities occur in approximately 2%-5% of all live births, accounting for up to 30% of pediatric hospital admissions and causing about 50% of childhood deaths in industrialized countries. However, the expanding scope of research in areas such as stem cell biology, neurobiology, and infectious diseases presents additional growth opportunities for the FISH Probe market. Additionally, limited reimbursement policies and the high cost of FISH assays may impede market growth.
Fluorescent in Situ Hybridization Probe Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.91% over the forecast period (2024-2032)
Based on Technology segmentation, Flow FISH was predicted to show maximum market share in the year 2023
Based on Type segmentation, DNA was the leading type in 2023
Based on Application segmentation, Cancer Research was the leading type in 2023
Based on End-user segmentation, Clinical was the leading type in 2023
On the basis of region, North America was the leading revenue generator in 2023
The Global Fluorescent in Situ Hybridization Probe Market is segmented on the basis of Technology, Type, Application, End-User, and Region.
There are three categories in which the market is segmented based on Technology: Flow FISH, Q FIH, and other technologies. Out of these, Flow FISH holds the largest market share. The continuous expansion of Flow FISH is anticipated due to advancements in genomics, personalized medicine, and molecular diagnostics. Additionally, the increasing research efforts in areas such as cancer biology, infectious diseases, and neurodegenerative disorders contribute to the growth of Flow FISH.
The market is segmented into two categories, DNA and RNA, with DNA holding the majority share. FISH probes are widely utilized in genetic mapping research to observe and study the spatial arrangement of DNA sequences in chromosomes. DNA plays a crucial role in genetics, genomics, molecular biology, and diagnostics across different fields.
The market is segmented into two categories according to Application: Cancer Research, Genetic Diseases, and Other. Cancer Research holds the largest share in the market. The Fluorescent in Situ Hybridization (FISH) probe market is crucial in cancer research as it allows for the identification and observation of particular genetic changes linked to different forms of cancer.
The market is segmented into two categories according to End-User: Research, Clinical, and Companion diagnostics. Clinical holds the majority share in the market. The Fluorescent in Situ Hybridization (FISH) probe market plays a crucial role in clinical settings, providing effective tools for genetic disorder diagnosis, chromosomal abnormality identification, and treatment decision support across different medical fields.
Fluorescent in Situ Hybridization Probe Market- Geographical Insights
Geographically, this market is spread across various regions including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided based on the countries involved in business activities. The market is expected to be dominated by North America, primarily due to the increasing R&D initiatives and the high prevalence of genetic disorders and cancer in this region. North America, especially the United States, has a strong ecosystem for biomedical research and innovation. In 2019, the U.S. research and experimental development (R&D) performance reached USD 667 billion, and it is estimated to have reached USD 708 billion in 2020, as reported by the National Science Foundation. Compared to other regions, North America has a relatively higher incidence of genetic disorders and cancer. According to the Center for Disease Control and Prevention, in the United States alone, there were 1,603,844 new cancer cases reported and 602,347 cancer-related deaths in 2020. This translates to 403 new cancer cases and 144 cancer-related deaths per 100,000 people. These statistics are based on the latest available data for the year 2020. Europe holds the second-largest region for market growth, primarily driven by the growing demand for personalized medicine.
In the Fluorescent in Situ Hybridization Probe Market, companies engage in fierce competition by offering a wide range of high-quality products. These products cater to various applications, including cancer diagnostics, genetic disorders, prenatal testing, and microbiology. To meet the diverse demands of customers, competitors focus on developing innovative probes that target specific genetic markers, chromosomal regions, or microbial species. To expand their market presence, companies establish a robust global network and distribution system. They also form partnerships, collaborations, and distribution agreements to enter new markets, reach customers in different regions, and grow their customer base. By ensuring a well-established distribution network, companies can provide timely delivery, technical support, and excellent customer service to end-users.
Fluorescence in situ hybridization (FISH) is a widely recognized technique for identifying nucleic acids within cells through the use of fluorescent probes. Nevertheless, the utilization of FISH in cancer diagnosis is constrained by the lengthy result processing time, the expensive nature of the procedure, and the intricate protocol involved.
GLOBAL FLUORESCENT IN SITU HYBRIDIZATION PROBE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Thermo Fisher Scientific Inc.
Perkinelmer Inc.
BioDot
Horizon Diagnostics
Agilent Technologies, Inc.
Abnova Corporation
LGC Biosearch Technologies
Genemed Biotechnologies, Inc.
Oxford Gene Technology IP Limited
Biocare Medical, LLC.
QIAGEN (Exiqon A/S)
GSP Research Institute, Inc.
Others